Boston University
Early detection of APOE4-associated blood-brain barrier and glial disruptions using integrated imaging and molecular profiling
Abstract
dc:description.abstractThe Apolipoprotein-E ε4 (APOE4) allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (LOAD) and may contribute to neurodegeneration through a multi-hit hypothesis, in which vascular dysfunction, glial activation, and impaired lipid metabolism play central roles. Recent evidence suggests that blood-brain barrier breakdown is an early feature of APOE4-mediated brain aging, potentially independent of the classical amyloid and tau pathologies. Astrocytes may play a crucial role in this pathway, not only as the primary source of APOE in the brain, but also as key regulators of the integrity of the neurovascular unit (NVU). To elucidate the underlying mechanisms, my dissertation investigates early-phase APOE4-specific blood-brain barrier (BBB) disruption and its association with astrocyte signaling and glial-neurovascular crosstalk, employing a multimodal framework that combines in vivo neuroimaging, ex vivo brain tissue histology, and transcriptomic profiling.By leveraging non-contrast multimodal magnetic resonance imaging (multi-echo time arterial spin labeling, T1-, and diffusion-weighted MRI), I detected regionally specific BBB leakage in the hippocampus of transgenic mice (6-8 months old) expressing human APOE4 (APOE4-KI) compared to those expressing APOE3 (APOE3-KI). Tissue microstructural alteration was also captured by diffusion MRI in the hippocampus, suggesting BBB-induced cellular environmental changes. These imaging findings were supported by immunohistochemistry, which revealed activation of the CypA-MMP9 pathway and localized vascular degradation specifically in the hippocampus. In addition, both imaging and histological BBB markers indicated more pronounced APOE4 effects in female mice. In parallel, astrocyte-specific changes, such as increased AQP4 and proinflammatory gene expression, suggested impaired astrocyte homeostasis in APOE4 carriers. Single-nucleus RNA sequencing and histological analyses identified a distinct population of reactive astrocytes enriched in APOE4 mice that may drive this early BBB disruption. Interactome analyses further revealed altered cell-cell communication strength between reactive astrocytes and pericytes, suggesting that astrocytic signaling may play a critical role in early vascular leakage and subtle cellular microstructural disruption in the hippocampus. These transcriptomic and proteomic patterns align with MRI-derived measures, supporting the sensitivity of imaging-based biomarkers to early pathological changes. Complementing these mouse model findings, analyses of three large-scale human datasets (Boston Puerto Rican Health Study, UK Biobank, and Alzheimer’s Disease Neuroimaging Initiative) revealed reduced hippocampal volume, accelerated neurovascular unit aging, particularly in individuals over 65 years old, when clinical symptoms of LOAD become apparent. These structural changes were associated with worse cognitive performance. As the NVU includes both the blood-brain barrier and perivascular brain clearance pathways, these results suggest that APOE4-related NVU vulnerability contributes to age- and sex-dependent structural and functional brain decline. Together, these findings demonstrate that in vivo non-contrast MRI can provide sensitive biomarkers for detecting APOE4-related neurovascular and glial dysfunction during the early stages of aging. The multimodal MRI can also provide cellular environmental changes associated with BBB damage. My work establishes a framework for linking macroscale imaging features to microscale cellular mechanisms, laying the foundation for developing non-invasive, personalized tools for early detection and longitudinal monitoring of neurovascular dysfunction in individuals at risk for LOAD.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Anatomy & Neurobiology
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Guan, Yi
- Advisor dc:contributor.advisor
-
- Koo, Bang-Bon
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53141